Innovative blood facility enables global disease research
A new facility in The School of Biological Sciences will investigate major global diseases and also screen the natural world for potential treatments.
The integrative blood coagulation research core facility will test all aspects of the blood coagulation system not only in human blood but also in diverse animals from bats to sharks.
Facility head Associate Professor Bryan Fry said The facility will have the ability to test all aspects of the blood coagulation system including anticoagulants, procoagulants, fibrinolysis, inflammatory proteins, thrombin generation and platelet aggregation..
“This array will serve multiple major needs currently unmet, ranging from basic biology to disease investigation to drug design and development
“Immediate projects will include not only investigating the pathophysiology of major global diseases such as plague but also screening natural products from Great Barrier Reef corals, for novel treatments of life-threatening conditions such as stroke,” he said
“The equipment will establish UQ at the forefront of blood coagulation research in Australia.”
Chief investigators on the application include researchers from the School of Biological Sciences, School of Biomedical Sciences, the Child Health Research Centre, Institute for Molecular Bioscience, UQ Diamantina Institute/Translational Research Institute, Australian Institute for Bioengineering and Nanotechnology, and the School of Chemistry and Molecular Biosciences.
Over $2.5 million will be invested in research equipment and infrastructure in the Faculty of Science through this year’s Major Equipment and Infrastructure (MEI) grants and Major Research Facility Fund (MRFF).